In an effort to improve the survival of patients with myeloproliferative neoplasms, a type of leukemia, researchers inhibited a specific protein (alpha5beta1 integrin) to decrease the number of large bone marrow cells (megakaryocytes) in an experimental model. An increase in megakaryocyte numbers is thought to be the cause of many problems observed in this disease. This type of treatment approach has never been attempted before.
- Patients of Asian and black backgrounds more likely to die from COVID, large study reveals
- Magnetic waves explain mystery of Sun’s outer layer
- CT identifies patients with high-risk nonalcoholic fatty liver disease (NAFLD)
- Research shows preference for male children is declining in Bangladesh
- Microbiome Search Engine 2 helps researchers explore microbiome space